LSA
FLNA

Leonteq Securities AG’s Filana Therapeutics FLNA Stock Holding History

Leonteq Securities AG’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,500
Closed -$41.6K – 1278
2023
Q3 		$41.6K Hold
2,500
– – ﹤0.01% 831
2023
Q2 		$61.3K Hold
2,500
– – ﹤0.01% 789
2023
Q1 		$60.3K Hold
2,500
– – ﹤0.01% 762
2022
Q4 		$73.8K Hold
2,500
– – ﹤0.01% 740
2022
Q3 		$105K Hold
2,500
– – ﹤0.01% 633
2022
Q2 		$70.3K Hold
2,500
– – ﹤0.01% 755
2022
Q1 		$92.8K Buy
+2,500
New +$106K ﹤0.01% 753
2021
Q1 		– Sell
-5,000
Closed -$34.1K – 1086
2020
Q4 		$34.1K Buy
+5,000
New +$44.6K ﹤0.01% 845

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Leonteq Securities AG's FLNA Position: Q4 2023 in Review

Leonteq Securities AG sold out of Filana Therapeutics (FLNA) in Q4 2023, closing a stake of 2,500 shares — an estimated $41.6K sold.

Leonteq Securities AG first reported a position in FLNA in Q4 2020 and held it in 8 quarters. The position peaked at $105K in Q3 2022. 153 funds tracked by Wall St. Rank hold FLNA as of Q4 2023.

  • Leonteq Securities AG reported no remaining Filana Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Leonteq Securities AG sold 2,500 Filana Therapeutics shares in Q4 2023, an estimated $41.6K.
  • Leonteq Securities AG first reported a position in Filana Therapeutics in Q4 2020 and held it in 8 quarters.
  • Leonteq Securities AG's Filana Therapeutics position peaked at $105K in Q3 2022.
  • 153 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2023.

Based on Leonteq Securities AG's 13F filing for Q4 2023, filed 11 Mar 2026.